MacroGenics (MGNX)
NASDAQ:MGNX
Holding MGNX?
Track your performance easily

MacroGenics (MGNX) Financial Statements

640 Followers

MacroGenics Financial Overview

MacroGenics's market cap is currently ―. The company's EPS TTM is $-2.186; its P/E ratio is -1.72; MacroGenics is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 110.71M$ 10.80M$ 9.10M$ 9.16M$ 10.40M
Gross Profit$ 110.54M$ 10.62M$ 8.83M$ 9.00M$ 10.31M
EBIT$ 56.31M$ -55.66M$ -49.21M$ -46.07M$ -25.90M
EBITDA$ 58.14M$ -52.53M$ -48.69M$ -44.17M$ -25.82M
Net Income Common Stockholders$ 56.31M$ -55.66M$ -52.19M$ -46.07M$ 24.10M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 179.63M$ 83.93M$ 80.36M$ 100.96M$ 89.90M
Total Assets$ 264.49M$ 201.14M$ 248.28M$ 298.42M$ 339.97M
Total Debt$ 34.10M$ 34.06M$ 34.01M$ 33.97M$ 34.11M
Net Debt$ -145.53M$ -49.88M$ -46.34M$ -66.98M$ -55.79M
Total Liabilities$ 144.43M$ 143.32M$ 142.13M$ 145.81M$ 145.99M
Stockholders Equity$ 120.07M$ 57.82M$ 106.15M$ 152.61M$ 193.98M
Cash Flow-
Free Cash Flow$ 59.65M$ -45.44M$ -47.10M$ -28.66M$ -35.73M
Operating Cash Flow$ 60.16M$ -44.48M$ -45.64M$ -28.04M$ -35.25M
Investing Cash Flow$ 35.60M$ 47.44M$ 24.79M$ 38.82M$ -33.52M
Financing Cash Flow$ -68.00K$ 625.00K$ 248.00K$ 273.00K$ 49.91M
Currency in USD

MacroGenics Earnings and Revenue History

MacroGenics Debt to Assets

MacroGenics Cash Flow

MacroGenics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis